Welcome to myAgios® Patient Support Services, helping you navigate the path ahead

myAgios is a customized support program for people living with thalassemia, designed to provide personalized education and treatment support.

Call myAgios today at 1‑877‑77‑AGIOS (1‑877‑772‑4467)

Language support is available.

Patient
Education

Looking for one-on-one disease education and support in talking to your doctor about treatment options? Connect with an Agios Clinical Educator (ACE).

Find your ACE

Getting
Medication

If you’ve been prescribed AQVESME, get help understanding insurance and coverage by connecting with a Patient Support Manager (PSM).

Find your PSM

One team to support people living with thalassemia!

ACEs and PSMs do not provide medical advice. For medical advice or treatment-related questions, please talk to your healthcare team.

For one-on-one education and learning about treatment options

Talk to an Agios Clinical Educator (ACE)

An ACE works closely with you, your family, and your healthcare team to provide education, resources, and community connections.

Your ACE can help with:

Individualized
Support

Meet with your ACE either in person or virtually to get compassionate support that will help you identify your goals, understand monthly monitoring requirements, and help you thrive

Educational
Resources

Find assistance with doctor discussions, information about your disease, explanations of the latest research, and monitoring considerations

Community
Connections

Build connections through webinars, events, advocacy groups, and others like you

Find your ACE

For help with getting AQVESME

Connect with a Patient Support Manager (PSM)

Your PSM will help you find ways to make it easier to get your AQVESME prescription in hand.

Your PSM can help with:

  • Filling and getting your AQVESME prescription

  • Clearing up any insurance confusion

  • Speaking and working with your doctor

  • Helping you set treatment goals

  • Connecting you to events and a wider community

Find your PSM

Getting AQVESME

Personalized Education

Every person's treatment experience is unique. We'll share information that is tailored to your needs so you understand what AQVESME is for, how it's taken, and what to expect along the way.

Our ACEs are here to support you pre- and post-treatment, and are waiting for you!

Support Through Enrollment

Getting started begins with a simple form. We'll guide you through the process, making sure you provide everything your doctor and insurance need.

You will need to provide your consent for myAgios to contact you and your health plan, which you can do at your doctor's appointment or electronically. We have translated consent forms in your native language readily available—just ask your PSM!

Insurance Made Clear

Insurance coverage can be confusing. Your PSM will review your plan, explain what is covered, and outline any next steps.

After your health plan approves your coverage, AQVESME will be shipped directly to you.

Programs Designed
to Help

You may be eligible for financial assistance or other support programs designed to make access to AQVESME easier. Our team can help you explore available options and see which ones may apply to you.

Have questions or issues getting your prescription?

Call us at 1‑877‑77‑AGIOS (1‑877‑772‑4467), Mon-Fri, 8 AM to 8 PM ET.

Not a native English speaker? No problem.

We have language translation services available in the following languages: 简体中文 (Chinese), يبرع (Arabic), Tiếng Việt (Vietnamese), ودرا (Urdu), हिंदी (Hindi), and many more.

For more information about treatment, visit AQVESME.com.

It’s rewarding to be able to help someone through challenges and provide tools for their treatment journey.

Lana, RN, BSN, PACS

Patient Support Manager

Getting Started on AQVESME: 3 Simple Steps

AQVESME is only available through the AQVESME Risk Evaluation and Mitigation
Strategy (REMS).

Once you and your doctor have reviewed AQVESME clinical and REMS information and
decided AQVESME is right for you, these are the steps to start treatment promptly:

You and your doctor complete and sign the AQVESME Start Form and your doctor completes AQVESME REMS certification

The AQVESME Start Form enrolls you in myAgios Patient Support Services. The myAgios team can assist you and your doctor in determining insurance coverage and exploring financial assistance options.

Complete liver test

A blood test to show how well your liver is working must be completed within 4 weeks of the first prescription being filled. The myAgios team will work with you and your doctor to determine the ideal timing for the required liver test based on the status of insurance determination.

Your doctor enrolls you in AQVESME REMS

To enroll, you and your doctor complete and sign the AQVESME REMS Patient Enrollment Form, including documentation of the liver test and confirmation that AQVESME is appropriate for you.

Your doctor can help answer questions along the way. For more information, visit AQVESMEREMS.com or call 1‑800‑625‑9951 Mon-Fri, 8 AM to 8 PM ET.

Your doctor will check your liver with a blood test before you start AQVESME, and then every 4 weeks for the first 24 weeks of treatment.

*AQVESME is one pill taken twice daily.

The myAgios team will ensure that AQVESME is delivered directly to your home through an exclusive REMS-certified Specialty Pharmacy.

For any questions regarding myAgios, visit myAgios.com or call 1‑877‑77‑AGIOS (1‑877‑772‑4467).

We have programs that take the worry
out of getting AQVESME

Financial support

We can figure out your needs and walk you through the financial assistance and coverage support programs that help people in different situations.

What type of health insurance do you have?

I have commercial insurance, either through my work or my family, or purchased through the marketplace.

$0 responsibility for those with commercial insurance who qualify, regardless of how much you make.

Please see full Terms and Conditions for more information.

Have questions about your eligibility for these programs? Get answers from a PSM.

Find your PSM

The AQVESME Copay Program lowers costs for eligible patients to $0

This program lowers costs for eligible patients to $0 per prescription if their copay exceeds that amount. To learn more about patient eligibility, call myAgios Patient Support Services at 1‑877‑77‑AGIOS (1‑877‑772‑4467), Mon-Fri, 8 AM to 8 PM ET.

Your ACE and your PSM are here to work as your team

ACE helps with:

  • One-on-one disease education and support in understanding treatment options
  • Monthly monitoring requirements for AQVESME
  • Support and resources for living with your condition
  • Community connections to others like you

PSM helps with:

  • Understanding your insurance
  • Getting AQVESME
  • Speaking and working with your doctor
  • Exploring ways to make AQVESME more affordable

Whether or not you are prescribed AQVESME, you can get connected today to your myAgios team. We’re ready!

Call us at 1‑877‑77‑AGIOS (1‑877‑772‑4467), Mon-Fri, 8 AM to 8 PM ET.

Language support is available.

myAgios resources & more

Get resources to help you along your myAgios path.

Find myAgios resources

Interested in AQVESME?

Learn more about the benefits and risks of AQVESME for those living with thalassemia.

Learn more about AQVESME
IMPORTANT SAFETY
INFORMATION

AQVESME may cause serious side effects, including:

  • Liver injury. AQVESME can cause serious liver injury. Liver injury has happened in people with thalassemia within the first 6 months of treatment with AQVESME. Your healthcare provider will do blood tests to check your liver before you start treatment with AQVESME, every 4 weeks for the first 24 weeks of treatment, and as needed. Your healthcare provider may temporarily or permanently stop your treatment with AQVESME if you have abnormal liver blood tests.
    Tell your healthcare provider right away if you develop any new or worsening signs or symptoms of liver problems, including:
    • loss of appetite
    • nausea
    • pain in the upper right side of your stomach area
    • vomiting
    • yellowing of the skin and white part of your eyes (jaundice)
    • dark-colored urine

In clinical studies of AQVESME, 2 of 301 people (0.66%) treated with AQVESME experienced adverse reactions suggestive of liver injury. Three additional people experienced adverse reactions suggestive of liver injury during the open-label extension periods, after switching from placebo to AQVESME. Of the 5 people, two had serious liver injury requiring hospitalization, including 1 who developed jaundice. Another developed jaundice without requiring hospitalization. All 5 people discontinued treatment with AQVESME, and these reactions improved upon treatment discontinuation.

Because of the risk for liver injury, AQVESME is only available through a restricted access program called the AQVESME Risk Evaluation and Mitigation Strategy (REMS).

Before taking AQVESME, tell your healthcare provider about all of your medical conditions, including if you:

  • have liver problems, such as cirrhosis
  • are pregnant or plan to become pregnant. It is not known if AQVESME will harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think that you are pregnant during treatment with AQVESME.
  • are breastfeeding or plan to breastfeed. It is not known if AQVESME passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with AQVESME.

Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Make sure to tell your healthcare provider if you take or use hormonal birth control (contraceptives). If you take or use hormonal birth control (except for intrauterine systems containing levonorgestrel), it may not work as well during treatment with AQVESME. Use a different type of birth control or use an additional nonhormonal birth control method (such as condoms) during treatment with AQVESME and for 28 days after stopping treatment with AQVESME. AQVESME and certain other medicines may affect each other and cause side effects. AQVESME may affect the way other medicines work, and other medicines may affect the way AQVESME works.

The most common side effects of AQVESME in patients:

  • headache
  • insomnia

These are not all of the possible side effects of AQVESME. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What is AQVESME?

AQVESME is a prescription medicine used to treat anemia (low red blood cells) in adults with alpha- or beta-thalassemia. It is not known if AQVESME is safe and effective in children.

Please see full Prescribing Information, including Medication Guide.